Using a Wearable Device and Patient Reported Outcome to Evaluate the Influence of Sleep on Quality of Life Among Breast and Prostate Cancer Patients

Dhar, Eshita; Barsasella, Diana; Srikanth, Sruthi; Panja, Ajith Kumar; Syed-Abdul, Shabbir

doi:10.3233/shti220132

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Chan et al found a dyadic association between psychological distress and sleep disturbance among Chinese patients with cancer and their spouses [ 7 ], which is similar to our study. Dhar et al implied that breast cancer patients who were poor and short sleepers showed greater deficits in QoL [ 13 ]. Our study also estimated that sleep quality has a positive correlation with the QoL, and both can be improved by the CALM intervention.…”

Section: Discussionmentioning

confidence: 99%

Impact of the CALM intervention on breast cancer patients during the COVID-19 pandemic

Pang

Yao

et al. 2023

Support Care Cancer

View full text Add to dashboard Cite

Objective The COVID-19 outbreak has adversely affected breast cancer patients both physically and mentally. Managing Cancer and Living Meaningfully (CALM) is a psychological intervention that is easy to implement. It also decreases the possibility of virus transmission because it can be administered online. Therefore, this study investigated the effects of CALM on the sleep quality, memory, psychological distress, and quality of life (QoL) of breast cancer patients during the ongoing COVID-19 pandemic. Methods Sixty breast cancer patients were recruited and randomly assigned to a CALM group and a Care as Usual (CAU) group. They filled in questionnaires before and after the CALM intervention and CAU. These included the Sleep Quality Scale (SQS), Prospective Memory Scale (PM), Retrospective Memory Scale (RM), Psychological Distress Thermometer (DT), and Quality of life (QoL) Scale. Results The scores of all the aforementioned scales after the CALM intervention (ACM) were significantly lower compared to the said scores before the CALM intervention (BCM) and after Care as Usual (ACU) ( t = 12.369/8.013, t = 8.632/4.583, t = 7.500/6.900, t = 12.479/9.780, t = 12.224/6.729 respectively, P < 0.05) There was a linear correlation between the QoL, DT, and SQS scores. Conclusion CALM is an effective psychotherapy for breast cancer patients, especially during the COVID-19 pandemic, for improving the QoL because it relieves psychological distress and enhances sleep quality.

show abstract

Section: Discussionmentioning

confidence: 99%

Impact of the CALM intervention on breast cancer patients during the COVID-19 pandemic

Pang

Yao

et al. 2023

Support Care Cancer

View full text Add to dashboard Cite

show abstract

“…In recent years, an increasing number of studies have used commercial wearables to measure sleep in clinical trials among cancer patients 28 , 29 . Research is also expanding to explore the potential role of these sleep trackers in measuring sleep in comparison to traditional sleep diaries.…”

Section: Discussionmentioning

confidence: 99%

Comparing sleep measures in cancer survivors: Self-reported sleep diary versus objective wearable sleep tracker

Li,

Mao,

Garland

et al. 2023

Preprint

View full text Add to dashboard Cite

Purpose Cancer survivors are increasingly using wearable fitness trackers, but it's unclear if they match traditional self-reported sleep diaries. We aimed to compare sleep data from Fitbit and the Consensus Sleep Diary (CSD) in this group. Methods We analyzed data from two randomized clinical trials, using both CSD and Fitbit to collect sleep outcomes: total sleep time (TST), wake time after sleep onset (WASO), number of awakenings (NWAK), time in bed (TIB) and sleep efficiency (SE). Insomnia severity was measured by Insomnia Severity Index (ISI). We used the Wilcoxon Singed Ranks Test, Spearman’s rank correlation coefficients, and the Mann-Whitney Test to compare sleep outcomes and assess their ability to distinguish insomnia severity levels between CSD and Fitbit data. Results Among 62 participants, compared to CSD, Fitbit recorded longer TST by an average of 14.6 (SD = 84.9) minutes, longer WASO by an average of 28.7 (SD = 40.5) minutes, more NWAK by an average of 16.7 (SD = 6.6) times per night, and higher SE by an average of 7.1% (SD = 14.4); but shorter TIB by an average of 24.4 (SD = 71.5) minutes. All the differences were statistically significant (all p < 0.05), except for TST (p = 0.38). Moderate correlations were found for TST (r = 0.41, p = 0.001) and TIB (r = 0.44, p < 0.001). Compared to no/mild insomnia group, participants with clinical insomnia reported more NWAK (p = 0.009) and lower SE (p = 0.029) as measured by CSD, but Fitbit outcomes didn’t. Conclusions TST was the only similar outcome between Fitbit and CSD. Our study highlights the advantages, disadvantages, and clinical utilization of sleep trackers in oncology.

show abstract

Using a Wearable Device and Patient Reported Outcome to Evaluate the Influence of Sleep on Quality of Life Among Breast and Prostate Cancer Patients

Cited by 2 publications

References 0 publications

Impact of the CALM intervention on breast cancer patients during the COVID-19 pandemic

Impact of the CALM intervention on breast cancer patients during the COVID-19 pandemic

Comparing sleep measures in cancer survivors: Self-reported sleep diary versus objective wearable sleep tracker

Contact Info

Product

Resources

About